Top Markets
Coin of the day
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
Ранг среди акций #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
Цена акции
$0.66936954
Последняя синхронизация: 2026-07-28
Рыночная капитализация
$89.04M
Изменение (1 день)
0.00%
Изменение (1 год)
-40.10%
Страна
TW
Торговля BRIM Biotechnology, Inc. (6885)

Категория

История цены акций BRIM Biotechnology, Inc. (6885)
Наивысшая цена закрытия: $0.68 2026-07-01

Наименьшая цена закрытия: $0.81 2022-06-01
История цены акций BRIM Biotechnology, Inc. с 2022 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -7.17%
2025 -13.55%
2024 -45.45%
2023 59.53%
2022 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH